Skip to main content

Want a detailed portfolio tracker?

Aardvark Therapeutics (AARD) P/E (2025 - 2026)

Aardvark Therapeutics (AARD) P/E from Mar 31, 2025 to Jun 3, 2026. The TTM Aardvark Therapeutics (AARD) P/E is -1.19. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Aardvark Therapeutics (AARD)

YearP/EChange
2026-1.19-76.04%
2025-4.95N/A

Comparison Aardvark Therapeutics (AARD) P/E with competitors

Aardvark Therapeutics (AARD) P/E is -1.19.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.14%
NBYStablecoin Development Corp0.10-108.61%
ENLVEnlivex Therapeutics Ltd0.15-112.65%
FGENFibroGen Inc0.24-120.22%
TRAWTraws Pharma Inc0.47-139.83%
FBIOFortress Biotech Inc0.71-159.47%
CHRSCoherus Biosciences Inc0.98-182.39%
ORMPOramed Pharmaceuticals Inc1.47-224.11%
AGENAgenus Inc2.05-272.55%
VIVSVivoSim Labs Inc2.54-313.59%
INVAInnoviva Inc3.19-368.57%
CRMDCorMedix Inc3.65-407.08%
ABEOAbeona Therapeutics Inc4.20-454.20%
VXRTVaxart Inc4.26-458.96%
CVACCureVac N.V.4.45-474.46%
SRPTSarepta Therapeutics Inc4.62-489.51%
GLPGGalapagos NV4.86-509.27%
RIGLRigel Pharmaceuticals4.92-514.38%
ZVRAZevra Therapeutics Inc4.97-518.97%
ABUSArbutus Biopharma Corp5.69-579.60%
CGENCompugen Ltd7.38-721.97%
AUPHAurinia Pharmaceuticals Inc9.25-879.28%
ACADAcadia Pharmaceuticals Inc9.59-907.63%
OMEROmeros Corporation9.88-932.51%
PLXProtalix BioTherapeutics Inc9.91-934.68%
SPROSpero Therapeutics Inc10.73-1004.22%
ADMAAdma Biologics Inc11.33-1054.42%
SVASinovac Biotech Ltd11.44-1063.30%
TBPHTheravance Biopharma Inc11.78-1091.99%
HRMYHarmony Biosciences Holdings Inc12.18-1126.00%
TGTXTG Therapeutics Inc13.18-1210.15%
INCYIncyte Corp13.38-1227.22%
SABSSAB Biotherapeutics Inc14.06-1284.13%
XOMAXOMA Corp14.95-1358.89%
REGNRegeneron Pharmaceuticals Inc14.98-1361.84%
PBYIPuma Biotechnology Inc15.05-1367.75%
EXELExelixis Inc15.79-1430.46%
NAGENiagen Bioscience Inc16.35-1477.64%
CPRXCatalyst Pharmaceuticals Inc17.34-1561.01%
MDXGMimedx Group Inc17.38-1563.59%
ARGXArgen X SE23.07-2043.40%
HALOHalozyme Therapeutics Inc23.20-2054.27%
XOMAOXOMA Corp25.34-2234.89%
VRTXVertex Pharmaceuticals Inc25.66-2261.08%
XOMAPXOMA Corp25.67-2262.29%
CTMXCytomX Therapeutics Inc25.70-2264.63%
ASNDAscendis Pharma A/S26.35-2319.90%
RPRXRoyalty Pharma plc - Class A27.50-2416.04%
SLNOSoleno Therapeutics Inc29.02-2544.07%
LGNDLigand Pharmaceuticals Inc - Class B30.19-2642.72%
BMRNBiomarin Pharmaceutical Inc37.51-3259.38%
APLSApellis Pharmaceuticals Inc39.02-3386.90%
KRYSKrystal Biotech Inc39.70-3443.88%
GMABGenmab40.20-3486.50%
ONCBeiGene Ltd67.03-5745.93%
TECHBio-Techne Corp68.59-5878.02%
VCELVericel Corp80.63-6891.70%
PHARPharming Group N.V.87.74-7490.69%
ALNYAlnylam Pharmaceuticals Inc124.93-10623.64%
TLXTelix Pharmaceuticals Ltd139.89-11883.52%
CORTCorcept Therapeutics Inc158.39-13441.73%